SCHEMBL23269705

SCHEMBL23269705

NN1CCC(N2CCC(N3CCN(CCO)CC3)CC2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
KMT2A Q03164 3/20 0.36
PKM P14618 1/20 0.36
SLC18A3 Q16572 1/20 0.35
LMNA P02545 2/20 0.33
HTT P42858 1/20 0.33
HCK P08631 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 1/20 0.33
KDM1A O60341 1/20 0.33
HSD11B1 P28845 1/20 0.33
MEN1 O00255 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SIGMAR1 Q99720 2/20 0.32
GNAI3 P08754 1/20 0.32
GNAO1 P09471 1/20 0.32
GNAI1 P63096 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23269644 0.83 L3MBTL1 (0.40) ALDH1A1KDM4EKMT2APKMSLC18A3
SCHEMBL5659414 0.81 ALDH1A1 (0.41) ALDH1A1KDM4EKMT2APKMSLC18A3
SCHEMBL23269702 0.80 KDM4E (0.37) ALDH1A1KDM4EKMT2APKMSLC18A3
SCHEMBL24207800 0.79 GNAI3 (0.44) ALDH1A1KMT2ASMN1; SMN2MAPTSIGMAR1
SCHEMBL28078036 0.78 GNAI3 (0.32) ALDH1A1KDM4EKMT2APKMSMN1; SMN2
SCHEMBL24454166 0.78 KMT2A (0.46) ALDH1A1KDM4EKMT2APKMSLC18A3
SCHEMBL24351554 0.78 KEAP1 (0.42) SMN1; SMN2SIGMAR1GNAI3GNAO1GNAI1
SCHEMBL23384127 0.77 LMNA (0.39) ALDH1A1KDM4EKMT2APKMSLC18A3
SCHEMBL163306 0.77 ALDH1A1 (0.52) ALDH1A1KDM4EKMT2APKMSLC18A3
SCHEMBL7671840 0.77 ALDH1A1 (0.52) ALDH1A1KDM4EKMT2APKMSLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021076886-A1 3-PHENYLSULPHONYL-QUINOLINE DERIVATIVES AS AGENTS FOR TREATING PATHOGENIC BLOOD VESSELS DISORDERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-04-22 WO disclosed